Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 1.19 B1.19 B1.22 B1.35 B1.3 B 5.06 B Research & development 239 M282 M310 M366 M304 M 1.26 B Operating income 43 M378 M366 M601 M179 M 1.52 B Non-Operating Income, Total 137 M139 M295 M479 M5.03 B 5.94 B Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 18 M24 M74 M139 M268 M 505 M Unusual income/expense 119 M115 M221 M340 M4.76 B 5.44 B Pretax income 332 M645 M746 M1.1 B5.1 B 7.6 B Equity in earnings 60 M67 M78 M64 M65 M 274 M Taxes 68 M153 M293 M-2.56 B354 M -1.76 B Non-controlling/minority interest 11 M-22 M1 M6 M4 M -11 M After tax other income/expense ————— — Net income before discontinued operations 254 M514 M452 M3.66 B4.75 B 9.38 B Discontinued operations ————— — Net income 254 M514 M452 M3.66 B4.75 B 9.38 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 254 M514 M452 M3.66 B4.75 B 9.38 B Basic earnings per share (Basic EPS) 0.921.891.6613.4517.65 34.65 Diluted earnings per share (Diluted EPS) 0.911.861.6413.2817.44 34.22 Average basic shares outstanding 275 M272 M272 M272 M269 M — Diluted shares outstanding 279 M276 M275 M276 M272 M — EBITDA 122 M469 M444 M682 M243 M 1.84 B EBIT -79 M260 M234 M272 M-99 M 667 M Cost of revenue 6.56 B7.27 B8.07 B8.63 B7.56 B 31.53 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 205 M205 M213 M407 M342 M 1.17 B